Cannasouth issues convertible notes after rescue package approved by Martin Lane August 6, 2024August 6, 2024 Cannasouth has issued NZ$1.22 million in convertible notes after a Deed of Company Arrangement (DOCA) aimed […]
Cannasouth given a ‘second chance’ as rescue plans approved by creditors by Steve Jones June 11, 2024June 13, 2024
‘Desperately needed’ export reforms back on agenda in New Zealand by Steve Jones April 23, 2024April 24, 2024
Cannasouth boss steps down in wake of voluntary administration by Martin Lane April 12, 2024July 16, 2024
Cannasouth enters trading halt amid risk to ‘urgent’ capital raise by Martin Lane March 26, 2024July 16, 2024
Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Job cuts and a cap raise loom for Cannasouth as NZ verification delays start to bite by Martin Lane October 3, 2023April 30, 2024
